Literature DB >> 17198749

Protein hormones and immunity.

Keith W Kelley1, Douglas A Weigent, Ron Kooijman.   

Abstract

A number of observations and discoveries over the past 20 years support the concept of important physiological interactions between the endocrine and immune systems. The best known pathway for transmission of information from the immune system to the neuroendocrine system is humoral in the form of cytokines, although neural transmission via the afferent vagus is well documented also. In the other direction, efferent signals from the nervous system to the immune system are conveyed by both the neuroendocrine and autonomic nervous systems. Communication is possible because the nervous and immune systems share a common biochemical language involving shared ligands and receptors, including neurotransmitters, neuropeptides, growth factors, neuroendocrine hormones and cytokines. This means that the brain functions as an immune-regulating organ participating in immune responses. A great deal of evidence has accumulated and confirmed that hormones secreted by the neuroendocrine system play an important role in communication and regulation of the cells of the immune system. Among protein hormones, this has been most clearly documented for prolactin (PRL), growth hormone (GH), and insulin-like growth factor-1 (IGF-I), but significant influences on immunity by thyroid-stimulating hormone (TSH) have also been demonstrated. Here we review evidence obtained during the past 20 years to clearly demonstrate that neuroendocrine protein hormones influence immunity and that immune processes affect the neuroendocrine system. New findings highlight a previously undiscovered route of communication between the immune and endocrine systems that is now known to occur at the cellular level. This communication system is activated when inflammatory processes induced by proinflammatory cytokines antagonize the function of a variety of hormones, which then causes endocrine resistance in both the periphery and brain. Homeostasis during inflammation is achieved by a balance between cytokines and endocrine hormones.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17198749      PMCID: PMC1894894          DOI: 10.1016/j.bbi.2006.11.010

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  55 in total

1.  Modulatory effect of prolactin on the resting and mitogen-induced activity of T, B, and NK lymphocytes.

Authors:  L Matera; A Cesano; G Bellone; E Oberholtzer
Journal:  Brain Behav Immun       Date:  1992-12       Impact factor: 7.217

Review 2.  Growth hormone, prolactin, and insulin-like growth factors: new jobs for old players.

Authors:  K W Kelley; S Arkins; Y M Li
Journal:  Brain Behav Immun       Date:  1992-12       Impact factor: 7.217

3.  Immunologic and hematologic effects of neuroendocrine hormones. Studies on DW/J dwarf mice.

Authors:  W J Murphy; S K Durum; M R Anver; D L Longo
Journal:  J Immunol       Date:  1992-06-15       Impact factor: 5.422

4.  Role of interferon-gamma in counteracting the suppressive effects of transforming growth factor-beta 2 and glucocorticoids on the production of tumor necrosis factor-alpha.

Authors:  D M Dunham; S Arkins; C K Edwards; R Dantzer; K W Kelley
Journal:  J Leukoc Biol       Date:  1990-12       Impact factor: 4.962

5.  Murine macrophages express abundant insulin-like growth factor-I class I Ea and Eb transcripts.

Authors:  S Arkins; N Rebeiz; A Biragyn; D L Reese; K W Kelley
Journal:  Endocrinology       Date:  1993-11       Impact factor: 4.736

Review 6.  Prolactin and growth hormone in the regulation of the immune system.

Authors:  R R Gala
Journal:  Proc Soc Exp Biol Med       Date:  1991-10

7.  A regulatory role of prolactin, growth hormone, and corticosteroids for human T-cell production of cytokines.

Authors:  S Dimitrov; T Lange; H L Fehm; J Born
Journal:  Brain Behav Immun       Date:  2004-07       Impact factor: 7.217

8.  Growth hormone augments superoxide anion secretion of human neutrophils by binding to the prolactin receptor.

Authors:  Y K Fu; S Arkins; G Fuh; B C Cunningham; J A Wells; S Fong; M J Cronin; R Dantzer; K W Kelley
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

9.  In vivo administration of recombinant growth hormone or gamma interferon activities macrophages: enhanced resistance to experimental Salmonella typhimurium infection is correlated with generation of reactive oxygen intermediates.

Authors:  C K Edwards; S M Ghiasuddin; L M Yunger; R M Lorence; S Arkins; R Dantzer; K W Kelley
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

10.  Differential effects of growth hormone and prolactin on murine T cell development and function.

Authors:  W J Murphy; S K Durum; D L Longo
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more
  51 in total

1.  Inflammation and mortality in a frail mouse model.

Authors:  Fred Ko; Qilu Yu; Qian-Li Xue; Wenliang Yao; Cory Brayton; Huanle Yang; Neal Fedarko; Jeremy Walston
Journal:  Age (Dordr)       Date:  2011-06-02

Review 2.  Extrapituitary production of anterior pituitary hormones: an overview.

Authors:  S Harvey; C Arámburo; E J Sanders
Journal:  Endocrine       Date:  2011-11-15       Impact factor: 3.633

Review 3.  Reversing T cell immunosenescence: why, who, and how.

Authors:  Pierre Olivier Lang; Sheila Govind; Richard Aspinall
Journal:  Age (Dordr)       Date:  2012-02-26

4.  Hypophysectomy and neurointermediate pituitary lobectomy decrease humoral immune responses to T-independent and T-dependent antigens.

Authors:  A Quintanar-Stephano; E Abarca-Rojano; R A Jarillo-Luna; V Rivera-Aguilar; J Ventura-Juárez; I Berczi; K Kovacs; R Campos-Rodríguez
Journal:  J Physiol Biochem       Date:  2010-04-21       Impact factor: 4.158

5.  Prototypical anti-inflammatory cytokine IL-10 prevents loss of IGF-I-induced myogenin protein expression caused by IL-1beta.

Authors:  Klemen Strle; Robert H McCusker; Rodney W Johnson; Samantha M Zunich; Robert Dantzer; Keith W Kelley
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-02-12       Impact factor: 4.310

Review 6.  Clinically feasible approaches to potentiating cancer cell-based immunotherapies.

Authors:  V I Seledtsov; A G Goncharov; G V Seledtsova
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 7.  Psychoneuroimmunology-developments in stress research.

Authors:  Rainer H Straub; Maurizio Cutolo
Journal:  Wien Med Wochenschr       Date:  2017-06-09

8.  Intracerebroventricular injection of leukotriene B4 attenuates antigen-induced asthmatic response via BLT1 receptor stimulating HPA-axis in sensitized rats.

Authors:  Shui-Juan Zhang; Yang-Mei Deng; Yi-Liang Zhu; Xin-Wei Dong; Jun-Xia Jiang; Qiang-Min Xie
Journal:  Respir Res       Date:  2010-04-20

9.  The landscape of human genes involved in the immune response to parasitic worms.

Authors:  Matteo Fumagalli; Uberto Pozzoli; Rachele Cagliani; Giacomo P Comi; Nereo Bresolin; Mario Clerici; Manuela Sironi
Journal:  BMC Evol Biol       Date:  2010-08-31       Impact factor: 3.260

10.  The DAF-2 insulin-like signaling pathway independently regulates aging and immunity in C. elegans.

Authors:  Eric A Evans; Will C Chen; Man-Wah Tan
Journal:  Aging Cell       Date:  2008-09-08       Impact factor: 9.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.